Cargando…
Orally active, species-independent novel A(3) adenosine receptor antagonist protects against kidney injury in db/db mice
Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease, and the current pharmacological treatment for DKD is limited to renin-angiotensin system (RAS) inhibitors. Adenosine is detectable in the kidney and is significantly elevated in response to cellular damage. While all 4 k...
Autores principales: | Dorotea, Debra, Cho, Ahreum, Lee, Gayoung, Kwon, Guideock, Lee, Junghwa, Sahu, Pramod K., Jeong, Lak Shin, Cha, Dae Ryong, Ha, Hunjoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938017/ https://www.ncbi.nlm.nih.gov/pubmed/29674631 http://dx.doi.org/10.1038/s12276-018-0053-x |
Ejemplares similares
-
Enrichment of Short-Chain Ceramides and Free Fatty Acids in the Skin Epidermis, Liver, and Kidneys of db/db Mice, a Type 2 Diabetes Mellitus Model
por: Kim, Minjeong, et al.
Publicado: (2019) -
A novel pan-Nox inhibitor, APX-115, protects kidney injury in streptozotocin-induced diabetic mice: possible role of peroxisomal and mitochondrial biogenesis
por: Kwon, Guideock, et al.
Publicado: (2017) -
Adenosine receptors as emerging therapeutic targets for diabetic kidney disease
por: Pak, Eun Seon, et al.
Publicado: (2022) -
Recent Insights Into SREBP as a Direct Mediator of Kidney Fibrosis via Lipid-Independent Pathways
por: Dorotea, Debra, et al.
Publicado: (2020) -
Celastrol, an NF-κB Inhibitor, Improves Insulin Resistance and Attenuates Renal Injury in db/db Mice
por: Kim, Jung Eun, et al.
Publicado: (2013)